Thermo Fisher Scientific Inc. $TMO Shares Bought by Public Sector Pension Investment Board

Thermo Fisher Scientific logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Public Sector Pension Investment Board increased its Thermo Fisher stake by 153.1% in the third quarter, adding 92,817 shares to hold 153,446 shares valued at about $101.8 million. Institutional investors own 89.23% of the company.
  • Thermo Fisher beat quarterly earnings and revenue estimates, reporting EPS of $6.68 and revenue of $12.14 billion; revenue rose 9.1% year over year.
  • Analyst sentiment is broadly positive: the stock has a “Moderate Buy” consensus rating and an average price target of $683.64. Company insiders sold 13,106 shares worth about $8.5 million over the past 90 days.
  • MarketBeat previews the top five stocks to own by December 1st.

Public Sector Pension Investment Board lifted its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) by 153.1% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 153,446 shares of the medical research company's stock after acquiring an additional 92,817 shares during the quarter. Public Sector Pension Investment Board's holdings in Thermo Fisher Scientific were worth $101,840,000 at the end of the most recent quarter.

A number of other hedge funds have also bought and sold shares of the business. BlackRock Inc. purchased a new stake in shares of Thermo Fisher Scientific during the 2nd quarter valued at $15,501,867,000. Corient Private Wealth LP purchased a new position in shares of Thermo Fisher Scientific in the 2nd quarter worth about $382,547,000. Bank of New York Mellon Corp purchased a new position in shares of Thermo Fisher Scientific in the 2nd quarter worth about $1,974,561,000. Bank of America Corp DE bought a new position in Thermo Fisher Scientific during the second quarter valued at about $1,952,930,000. Finally, Legal & General Group Plc bought a new position in Thermo Fisher Scientific during the second quarter valued at about $1,122,351,000. 89.23% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In related news, VP Lisa P. Britt sold 2,831 shares of the stock in a transaction dated Wednesday, October 28th. The stock was sold at an average price of $706.45, for a total transaction of $1,999,959.95. Following the sale, the vice president owned 11,560 shares of the company's stock, valued at approximately $8,166,562. This represents a 19.67% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Marc N. Casper sold 10,000 shares of the firm's stock in a transaction dated Thursday, August 20th. The stock was sold at an average price of $629.27, for a total value of $6,292,700.00. Following the completion of the transaction, the chief executive officer owned 123,925 shares of the company's stock, valued at approximately $77,982,284.75. This represents a 7.47% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 13,106 shares of company stock valued at $8,465,099 over the last ninety days. Corporate insiders own 0.33% of the company's stock.

Analysts Set New Price Targets

Several analysts have commented on TMO shares. Sanford C. Bernstein lifted their price objective on shares of Thermo Fisher Scientific from $520.00 to $575.00 and gave the stock a "market perform" rating in a research report on Friday, July 24th. Rothschild & Co Redburn increased their target price on shares of Thermo Fisher Scientific from $725.00 to $750.00 and gave the company a "buy" rating in a research report on Thursday, October 22nd. Guggenheim initiated coverage on shares of Thermo Fisher Scientific in a research note on Thursday, October 15th. They set a "buy" rating and a $740.00 price target for the company. Leerink Partners lifted their price target on shares of Thermo Fisher Scientific from $600.00 to $620.00 and gave the stock an "outperform" rating in a report on Wednesday, July 22nd. Finally, Wells Fargo & Company downgraded Thermo Fisher Scientific from an "overweight" rating to an "underweight" rating in a research note on Wednesday, September 9th. Two investment analysts have rated the stock with a Strong Buy rating, twenty-three have issued a Buy rating and four have given a Hold rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $683.64.

View Our Latest Stock Report on Thermo Fisher Scientific

Thermo Fisher Scientific Price Performance

NYSE TMO opened at $686.70 on Wednesday. The company has a quick ratio of 1.41, a current ratio of 1.81 and a debt-to-equity ratio of 0.71. The company has a market cap of $254.43 billion, a PE ratio of 27.97, a price-to-earnings-growth ratio of 2.82 and a beta of 0.84. Thermo Fisher Scientific Inc. has a 52 week low of $435.27 and a 52 week high of $727.56. The firm's 50-day simple moving average is $674.07 and its two-hundred day simple moving average is $557.70.

Thermo Fisher Scientific (NYSE:TMO - Get Free Report) last posted its earnings results on Wednesday, October 21st. The medical research company reported $6.68 earnings per share for the quarter, topping the consensus estimate of $6.40 by $0.28. The firm had revenue of $12.14 billion during the quarter, compared to the consensus estimate of $11.95 billion. Thermo Fisher Scientific had a net margin of 14.94% and a return on equity of 17.33%. The company's revenue was up 9.1% on a year-over-year basis. During the same quarter last year, the company earned $5.79 earnings per share. Research analysts predict that Thermo Fisher Scientific Inc. will post 25.26 earnings per share for the current year.

Thermo Fisher Scientific Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, January 15th. Shareholders of record on Tuesday, December 15th will be given a dividend of $0.47 per share. The ex-dividend date is Tuesday, December 15th. This represents a $1.88 annualized dividend and a dividend yield of 0.3%. Thermo Fisher Scientific's dividend payout ratio is currently 9.92%.

Thermo Fisher Scientific Profile

(Free Report)

Thermo Fisher Scientific develops and supplies products and services used in scientific research, clinical diagnostics, and pharmaceutical and biotechnology manufacturing. Its offerings include laboratory instruments, reagents and consumables, analytical equipment, diagnostic tests, and services that support drug development and clinical research. The company operates through businesses focused on life sciences, analytical instruments, specialty diagnostics, and laboratory products and biopharma services.

Featured Articles

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Thermo Fisher Scientific Right Now?

Before you consider Thermo Fisher Scientific, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Thermo Fisher Scientific wasn't on the list.

While Thermo Fisher Scientific currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines